Clinical trials recruiting for Relapse
3
Recruiting trials
1
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 2Phase 2 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Cyclophosphamide | 1 |
| Fludarabine | 1 |
| Second-Line Chemo/Targeted Therapy | 1 |
| Serplulimab | 1 |
| iC9-CAR.B7-H3 T Cell Therapy | 1 |
| iC9-CAR.B7-H3 T cell infusion | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| North Carolina | 2 |
Top cities
Self-screener
Recruiting trials
- A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant Chemotherapy
- Autologous CAR-T Cells Targeting B7-H3 in PDAC
- Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
Related conditions
Trials recruiting for Relapse often also study these conditions. Each links to its own recruiting-trial list.
Triple-negative breast cancer 138Pancreatic cancer 870Pancreas Cancer 86Colorectal cancer 1359Breast cancer 2239
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Relapse trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.